Friday, 29 March 2024
Albany Molecular Research Inc.
13:45 | 23/2/18
Albuquerque Journal
AMRI, previously called Albany Molecular Research Inc., paid $110 million in 2014 to acquire its Albuquerque facilities from Oso Biopharmaceuticals Manufacturing LLC, a homegrown New Mexico company that itself acquired the injectable-drug operation ...
more»
00:48 | 22/2/18
The Ledger Gazette
Albany Molecular Research logo Albany Molecular Research, Inc. is a contract research and manufacturing company. The Company operates through Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), Drug Product (DP) and Fine ...
more»
02:18 | 7/12/17
Dispatch Tribunal
Albany Molecular Research logo California State Teachers Retirement System cut its position in Albany Molecular Research, Inc. (NASDAQ:AMRI) by 10.4% during the second quarter, according to the company in its most recent disclosure with the Securities ...
more»
01:45 | 5/12/17
StockNewsTimes
Albany Molecular Research logo State Street Corp raised its holdings in shares of Albany Molecular Research, Inc. (NASDAQ:AMRI) by 1.7% during the second quarter, according to its most recent filing with the SEC.
more»
01:45 | 3/12/17
StockNewsTimes
Albany Molecular Research earned a news impact score of 0.28 on Accern's scale. Accern also assigned media headlines about the biotechnology company an impact score of 43.8204509824352 out of 100, indicating that recent news coverage is somewhat ...
more»
01:22 | 28/11/17
Dispatch Tribunal
Albany Molecular Research logo California State Teachers Retirement System reduced its holdings in shares of Albany Molecular Research, Inc. (NASDAQ:AMRI) by 10.4% in the 2nd quarter, according to its most recent filing with the Securities and ...
more»
14:41 | 27/11/17
StockNewsTimes
Albany Molecular Research logo Northern Trust Corp lifted its position in shares of Albany Molecular Research, Inc. (NASDAQ:AMRI) by 4.3% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange ...
more»
14:18 | 26/11/17
The Ledger Gazette
Albany Molecular Research logo Vanguard Group Inc. lifted its position in Albany Molecular Research, Inc. (NASDAQ:AMRI) by 18.3% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission.
more»
22:22 | 25/11/17
StockNewsTimes
Albany Molecular Research logo State Street Corp boosted its holdings in Albany Molecular Research, Inc. (NASDAQ:AMRI) by 1.7% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission.
more»
01:56 | 24/11/17
WeeklyHub
Investors sentiment increased to 1.27 in 2017 Q2. Its up 0.01, from 1.26 in 2017Q1. It is positive, as 35 investors sold AMRI shares while 28 reduced holdings.
more»
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |